- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Mar 28, 2023
Highlights
- Market Cap
- $15.50M
- Enterprise Value
- $45.78M
- EPS (TTM)
- $0.03
- PE Ratio
- 63.68
- PEG Ratio
- 4.71
- Total Revenue (TTM)
- $44.19M
- Gross Profit (TTM)
- $15.78M
- EBITDA (TTM)
- $4.75M
- Year Range
- $1.64 - $17.18
- ROA (TTM)
- 9.12%
- ROE (TTM)
- 16.42%
- Avg. Volume (1M)
- 15K
- Avg. Volume Value (1M)
- $30.94K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ZJYL Performance Chart
Jin Medical International Ltd (ZJYL) is down 55.0% since the beginning of the year. At $2 per share, ZJYL is trading 88.5% below its 52-week high of $17.
Loading charts...
Compare this symbol against anything
Returns By Period
Jin Medical International Ltd (ZJYL) has returned -55.00% so far this year and -84.55% over the past 12 months.
Jin Medical International Ltd
- 1D
- 3.66%
- 1M
- 1.02%
- 6M
- -28.00%
- YTD
- -55.00%
- 1Y
- -84.55%
- 3Y*
- -46.61%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -34.14%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
ZJYL Monthly Returns History
Based on dividend-adjusted daily data since Mar 28, 2023, ZJYL's average daily return is +0.48%, while the average monthly return is +20.82%. At this rate, an investment would double in approximately 0.3 years.
Historically, 44% of months were positive and 56% were negative. The best month was Dec 2023 with a return of +931.0%, while the worst month was Oct 2023 at -62.2%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.
On a daily basis, ZJYL closed higher 46% of trading days. The best single day was Dec 18, 2023 with a return of +263.7%, while the worst single day was Feb 9, 2024 at -42.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -37.50% | 5.53% | -30.39% | 4.46% | 6.16% | -18.75% | 8.79% | -55.00% | |||||
| 2025 | 13.07% | -21.85% | 8.12% | 22.41% | -17.47% | -13.45% | -1.14% | 10.61% | -20.51% | -59.65% | 10.53% | -12.70% | -71.73% |
| 2024 | 6.53% | -52.47% | -38.85% | -0.78% | -28.08% | -5.11% | 7.69% | 7.50% | -10.63% | -25.65% | -54.50% | -14.48% | -93.73% |
| 2023 | -6.87% | 2.42% | -25.01% | 99.42% | 24.72% | -7.73% | 78.22% | -62.22% | 172.17% | 930.96% | 3,000.62% |
Benchmark Metrics
Jin Medical International Ltd has an annualized alpha of 166.07%, beta of 1.10, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 28, 2023.
- This stock participated in 296.64% of S&P 500 Index downside but only 6.36% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 166.07%
- Beta
- 1.10
- R²
- 0.01
- Upside Capture
- 6.36%
- Downside Capture
- 296.64%
Return for Risk
Risk / Return Rank
ZJYL ranks 7 for risk / return — above 7% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Jin Medical International Ltd (ZJYL) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZJYL | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.27 | ||
| Sortino ratioReturn per unit of downside risk | -3.83 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 1.25 | -0.49 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 2.00 | -2.95 |
| Martin ratioReturn relative to average drawdown | -1.15 | 8.49 | -9.65 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Jin Medical International Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Jin Medical International Ltd was 99.34%, occurring on Jul 9, 2026. The portfolio has not yet recovered.
The current Jin Medical International Ltd drawdown is 99.28%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.34%Jul 2026 | 2y 5mo | — | 2y 6moJan 2024 - now | — |
-69.42%Jan 2024 | 8d | 14d | 22dJan 2024 - Jan 2024 | — |
-68.65%Oct 2023 | 26d | 1mo 7d | 2mo 3dOct 2023 - Dec 2023 | — |
-44.06%May 2023 | 20d | 21d | 1mo 11dMay 2023 - Jun 2023 | — |
-38.11%Dec 2023 | 1d | 1d | 2dDec 2023 - Dec 2023 | — |
Drawdown Indicators
| ZJYL | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.34% | -56.78% | -42.56% |
Max Drawdown (1Y)Largest decline over 1 year | -89.35% | -9.10% | -80.25% |
Max Drawdown (3Y)Largest decline over 3 years | -99.34% | -18.90% | -80.44% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.28% | -1.58% | -97.70% |
Average DrawdownAverage peak-to-trough decline | -72.69% | -10.70% | -61.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 73.29% | 2.14% | +71.15% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Jin Medical International Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Jin Medical International Ltd is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ZJYL, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, ZJYL has a P/E ratio of 63.7. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ZJYL compared to other companies in the Medical Instruments & Supplies industry. ZJYL currently has a PEG ratio of 4.7. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ZJYL relative to other companies in the Medical Instruments & Supplies industry. Currently, ZJYL has a P/S ratio of 7.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ZJYL in comparison with other companies in the Medical Instruments & Supplies industry. Currently, ZJYL has a P/B value of 10.5. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ZJYL
Add Jin Medical International Ltd to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ZJYL